The management of drooling in motor neurone disease.
Drooling is a common and potentially distressing symptom in those with motor neurone disease. A coordinated multidisciplinary approach is required to optimally manage this symptom. Both pharmacological and non-pharmacological strategies are required, and when drugs are used, off-label prescribing in terms of indication or route of administration is common. Further research needs to explore ways of enhancing swallowing ability as well as ways of optimizing drug therapies.
Pilgrims Hospices, East Kent, Canterbury, Kent, United Kingdom.
Pauline
P
Dand
Mohamed
M
Sakel
D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000451:nursing; D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D009730:Nursing Assessment; D012798:Sialorrhea / Q000209:etiology / Q000517:prevention & control*
D018727:Muscarinic Antagonists; D001905:Botulinum Toxins